Due to interest in the COVID-19 vaccines, we are experiencing an extremely high call volume. Please understand that our phone lines must be clear for urgent medical care needs. We are unable to accept phone calls to schedule COVID-19 vaccinations at this time. When this changes, we will update this website. Our vaccine supply remains limited. Read all COVID-19 Vaccine Information.
Patient Care Options | Visitor Guidelines | Coronavirus Information | Self-Checker | Get Email Alerts
Enter the last name, specialty or keyword for your search below.
The Hinxton Group, An International Consortium on Stem Cells, Ethics & Law, an esteemed, international and interdisciplinary group of individuals interested in ethical and well-regulated science, most recently issued a consensus statement entitled Science, Ethics and Policy Challenges of Pluripotent Stem Cell-Derived Gametes, the purpose of which is to outline a set of principled recommendations for how work in this area ought to proceed in the context of national variations in policy. Debra Mathews, Ph.D., Assistant Director for Science Programs, Berman Institute of Bioethics, sits on its steering committee; Jeremy Sugarman, M.D., Harvey M. Meyerhoff Professor of Bioethics and Medicine, is a member.
It is the policy of the Johns Hopkins University School of Medicine that all research using human embryonic stem cells being conducted by faculty, staff or students or involving the use of JHU SOM facilities is subject to oversight by the Embryonic Stem Cell Research Oversight committee. All such research must be approved by the JHU SOM ESCRO committee.
Language Assistance Available:
© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.
